Provider of drugs designed to provide treatment of cancer. The company's drugs are use to treat cancer using antibodies derived from cohorts of patients, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Oct-2018 | 00.00 | Completed | Out of Business | ||
1. Early Stage VC (Series A) | 12-Jan-2009 | 00.00 | 00.00 | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Edward Stuart Ph.D | Co-Founder & Chief Executive Officer | ||
Alexander Knuth | Scientific Founder |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial